Exemplis Discimus 2008, 152(2):251-258

Mauris eu magna at sapien molestie pellentesque..

Jinn-Tu Cataa, Cyern Barrisa,c, Jami Thanea, Riyec Zhetb, Sim Surrelc, Crevil Donosc, Ava Lonarcchc
a Institute of Dermato-venerology, University of Quence, Hoth Republic
b Centre of Radiology, Faculty Hospital of Mon Calamari, Nar Shaddaa Republic
c Department of Neurosciences, Auril University Hospital, Republic of Polis Massa

BACKGROUND: Ut nisi ipsum, aliquet eget, varius in, gravida quis, turpis. Phasellus felis felis, gravida at, suscipit ac, dignissim quis, velit. Praesent purus odio, facilisis eget, luctus ac, mattis ac, felis. Donec eget ipsum sit amet libero scelerisque tempor. Maecenas sed sapien non metus ullamcorper rhoncus. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Integer pede magna, dictum quis, pulvinar ac, elementum sodales, metus. Sed id tortor faucibus tortor mollis sagittis.

METHODS AND RESULTS: Etiam lacus justo, dignissim ut, mattis id, lobortis vitae, nisi. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer eros purus, sagittis nec, malesuada tincidunt, imperdiet nec, erat. Donec est leo, interdum ut, consectetuer eget, vulputate mattis, justo. Maecenas nisl lorem, congue vitae, condimentum eu, pulvinar vel, nisl.. Praesent tellus lectus, dignissim quis, pellentesque sit amet, fringilla et, sem. Cras metus diam, convallis non, adipiscing eget, semper in, odio. Donec quis elit eu massa fringilla faucibus.

CONCLUSION: Vestibulum luctus, ligula quis aliquam fermentum, risus purus laoreet tellus, eget tempus purus nisi vitae eros. Donec vulputate, tellus non posuere tincidunt, libero nisi auctor mauris, sit amet scelerisque ipsum metus ut lectus.

Kľúčové slová: Nulla lobortis, Mauris ut mauris, Fusce lectus, Nullam pulvinar, Phasellus ac mi, Praesent arcu, Phasellus nunc, Nunc viverra, Ut adipiscing, In turpis, Mauris vehicula, Fusce eu lacus, Curabitur eu urna, Nullam quam, Curabitur non felis

Vložený: July 10, 2008; Přijatý: August 18, 2008; Uverejnené: December 1, 2008 

Zobraziť celý článok

Referencie

  1. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999; 56:33-39. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  2. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, et al. Diff erentiation of Atypical Parkinsonian Syndromes with Routine MRI. Neurology. 2000; 54:697-702. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  3. Brucke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, et al. Measurement of the Dopaminergic Degeneration in Parkinsons Disease with [123I]-CIT and SPECT: Correlation with Clinical Findings and Comparison with Multiple System Atrophy and Progressive Supranuclear Palsy. J Neural Transmit. 1997; 50(Suppl.):9-24. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  4. Booij J, Speelman JD, Horstink MWIM, Wolters EC. The Clinical Benefi t of Imaging Striatal Dopamine Transporter with [123I]FP-CIT SPECT in Diff erentiating Patients with Presynaptic Parkinsonism from those with Other Forms of Parkinsonism. Eur J Nuclear Med. 2001; 28:266-272. Prejsť k pôvodnému zdroju...
  5. Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, et al. [123I]beta-CIT and SPECT in Essential Tremor and Parkinsons Disease. J Neural Transm. 1998; 105:1213-1228. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  6. Berg D, Becker G, Zieler B, Tucha O, Hofman E, Preier M, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology. 1999; 53:1026-1031. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  7. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, et al. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound in Medicine and Biology. 2007; 33:15- 25. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  8. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Movement Disorders. 2001; 16:23-32. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  9. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinsons disease visualized by transcranial color-coded real-time sonography. Neurology. 1995; 45:182-184. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  10. Berg D, Siefker Ch, Ruprecht -Dörfl er P., Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology. 2001; 56:13-17. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  11. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increase in Parkinsons disease. J Neural Transm. 2002; 109:191- 196. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  12. Školoudík D, Škoda O, Bar M, Brozman M, Václavík D. Neurosonologie. Galén:Praha. 2003; 243-245.
  13. Skoloudik D, Fadrna T, Bartová P., Langova K, Ressner P, Zapletalova O, Hlusik P, Herzig R, Kanovsky P. Reproducibility of sonographic measurement of the substantia nigra. Ultrasound Med Biol. 2007; 33:1347-1352. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  14. Berg D, Grote C, Rausch WD, Maurer M, Wiesmann W, Reder P, et al. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol. 1999; 25:901-904. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  15. Berg D, Roggendorf W, Schroder U, Klein R, Tatschner T, et al. Echogenicity of Substantia Nigra, Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol. 2002; 59:999-1005. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  16. Ressner P, Skoloudik D, Hustik P, Kanovsky P. Echogenicity of substantia nigra in Parkinsons disease pilot study. J Neuroimaging. 2007; 17:164-167. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  17. Ressner P, Skoloudik D, Kanovsky P. Echogenita substantia nigra u Parkinsonovy nemoci pilotni studie. Cesk Slov Neurol N. 2006; 102:376-379.
  18. Constantinescu R, Ravina B, Berg D. Should transcranial sonography be used for the diagnosis of Parkinsons disease, controversy. Moving Along. Epub 2006:1205.
  19. Bartova P, Skoloudik D, Fadrna T, Ressner P, Bar M, Herzig R, Kanovsky P. Ultrazvukove hodnoceni substantia nigra u pacientu s parkinsonskymi syndromy, Cesk Slov Neurol N 2007; 103:653- 657.
  20. Bartova P, Skoloudik D, Fadrna T, Ressner P, Kanovsky P, Herzig R. Sonographic evaluation of substantia nigra in parkinsonian syndromes. Parkinsonism and Related disorders 2007; 13(Suppl 2):123.
  21. Berg D, Siefker Ch, Becker G. Echogenicity of the substantia nigra in Parkinsons disease and its relation to clinical fi ndings. J Neurol. 2001; 248:684-689. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  22. Ruprecht-Dörfl er P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinsons disease. Neuro Image. 2003; 18:416-422. Prejsť na PubMed...
  23. Semmer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, et al. Detection of presymptomatic Parkinsons disease: combining smell tests, transcranial sonography and SPECT. Mov Disord. 2004; 19:1196-1202. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  24. Berg D, Supprian T, Hofmann E, Zeiler B, Jäger A, Lange KW, et al. Depression in Parkinsons disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol. 1999; 246:1186-1193. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  25. Becker G, Berg D, Lesch KP, Becker T. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI fi ndings. The Int J Neuropsychopharmacology. 2001; 4:21-31. Prejsť k pôvodnému zdroju...
  26. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, et al. Parkinsons disease and depression: evidence for alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry. 1997; 63:590-595. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  27. Berg D, Jabs B, Merschodorf U, Beckmann H, Becker G. Echogenicity of substantia Nigra Determined by Transcranial Ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry. 2001; 50:463-467. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  28. Rouault TA, Cooperman S. Brain Iron Metabolism. Semin Pediatr Neurol. 2006; 13:142-148. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  29. Felletschin B, Bauer P, Walter U, Behnka S, Spiegel J, Csoti I, et al. Screening for mutations of the ferritin light and heavy genes in Parkinsons disease patients with hyperechogenicity of the substatnia nigra. Neuroscie Lett. 2003; 352:53-56. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  30. Hochstrasser H, Baeur P, Walter U, Behnke S, Spiegel J, Csoti I, et al. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology. 2004; 63:1912-1917. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  31. Martinez-Heranndez R, Mountes S, Higuera-Callleja J, Rios C. Plasma ceruloplasmin ferroxidase activity cerrelates with substatnia nigra sonographic area in Parkinsons disease patients. Mov disord. 2007; 22(Suppl 1):640.
  32. Salazar J, Mena N, Nunez MT. Iron dyshomeostasis in Parkinsons disease. J Neural Transm Suppl. 2006; 71:205-213. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  33. Zecca L, D Tampellini, Gerlach M, Riederer P, Fariello RG, Schulzer D. Substantia nigra neuromelanin:structure, synthesis,and molecular behaviour. J Clin Mol Pathol. 2001; 54:414-418.
  34. Zecca L, Berg D, Atzberger T, Ruprecht P, Rausch WD, Musico M, et al. In vivo detection of iron and neuromelanin by transcranial sonography: a new aproach for early detection of substantia nigra damage. Mov Disord. 2005; 20:1278-1285. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  35. Behnke S, Berg D, Naumann M, Becker G. Diff erentiation of Parkinsons disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry. 2005; 76:423- 425. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  36. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressle D. Brain parenchyma sonography discriminates Parkinsons disease and atypical parkinsonian syndromes. Neurology. 2003; 60:74-77. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  37. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clinical Auton Res. 1998; 8:359-362. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  38. Růžička E, Roth J, Kaňovský P. Parkinsonova nemoc a parkinsonské syndromy. Praha: Galén. 2000; 118-165.
  39. Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R: Sonographic discrimination of corticobasal degeneration vs. Progressive supranuclear palsy. Neurology. 2004; 63:504-509. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  40. Jankovic J. Essencial Tremor: clinical characteristics. Neurology. 2000; 54(Suppl 4):S21-S25.
  41. Niehaus L, Savyer N, Weber U, Hertel R, Trottenberg T, Kupsch A. Brain parenchyma sonography in patients with essential tremor and Parkinsons disease. Cerebrovasc Dis. 2004; 17(Suppl 4):3.
  42. Stockner H, Sojer M, Muler J, Wenning GK, Schmidauer C, Poewe W. Midbrain sonography in patients with essential tremor. Mov Disord. 2007; 22:414-417. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  43. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D: Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology. 2005; 64:1726-1732. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  44. Tsai CF, Wu RM, Huang YW, Chen LL, Yip PK, Jeng JS: Transcranial color-coded sonography helps diff erentiation between idiopatic Parkinsons disease and vascular parkinsonism. J Neurol. 2007; 254:501-507. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  45. Thanvi B, Lo N, Robinson T. Vascular parkinsonism an important cause of parkinsonism in older people. Age and Ageing. 2005; 34:114-119. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  46. Demirkiran M, Bozdemir H, Sarica Y. Vascular Parkinsonism: a distinct, heterogenous clinical entity. Acta Neurol Scand. 2001; 104:63-67. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  47. Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinsons disease with dementia. J Neurol. 2006; 253:448-454. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  48. Postert T, Lack B, Kuhn W, Jergas M, Andrich J, Braun B, et al. Basal ganglia alterations and brain atrophy in Huntingtons disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry. 1999; 67:457-462. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  49. Dexter DT, Jenner P, Scharpira AHV, Marsden CD. Alteration in levels of Iron, ferritin, and other trace metals in neurodegenerative diseases aff ecting the basal ganglia. Ann Neurol. 1992; 32(Suppl): S94-S100. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  50. Postert T, Eyding J, Berg D, Przuntek H, Becker G, Flinger M, et al. Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm. 2004; 68(Suppl):123-133. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  51. Dürr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease. Clinical, molecular and neuropathological features. Ann Neurol. 1996; 39:490-499. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  52. Naumann M, Becker G, Tokya KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopatic dystonia detected by transcranial sonography. Neurology. 1996; 47:1284-1290. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  53. Becker G, Berg D, Francis M, Naumann M. Evidence for disturbances of copper metabolism in dystonia: From the image towards a new concept. Neurology. 2001; 57:2290-2294. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  54. Allen RP, Barket PB, Wehr F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001; 56:263-265. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  55. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4:101-119. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  56. Schmidauer C, Sojer M, Seppi K, Stockner H, Hogl B, Biedermann B, et al: Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005; 58:630-634. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  57. Godau J, Schweitzer KJ, Liepelt I, Gerloff Ch, Berg D. Substantia nigra hyperechogenicity: Defi nition and fi ndings in restless legs syndrome. Mov Disod. 2007; 22:187-192. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  58. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004; 19:1445-9. Prejsť k pôvodnému zdroju... Prejsť na PubMed...
  59. Berg D, Schweitzer K, Leitner P, Zimprich A, Lichtner P, Belcredi P, et al. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 2005; 128:3000-11. Prejsť k pôvodnému zdroju... Prejsť na PubMed...

Späť na obsah